Jul 3 |
How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
|
Jun 27 |
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
Jun 25 |
Roche’s Ocrevus SC administration approved by European Commission
|
Jun 25 |
Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
|
Jun 24 |
Halozyme Therapeutics (NASDAQ:HALO) shareholder returns have been stellar, earning 193% in 5 years
|
Jun 21 |
Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy
|
Jun 21 |
Bristol Myers Opdivo injectable accepted for EU review
|
Jun 20 |
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
Jun 15 |
The 3 Best Healthcare Stocks to Buy in June 2024
|
Jun 14 |
Why Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
|